• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Scanfil Q3'25 earnings preview: Turn to earnings growth  

SCANFLAnalyst Comment20.10.2025 klo 10.01
Antti ViljakainenHead of Research
Discuss
Estimates Q3'24Q3'25Q3'25eQ3'25eConsensus2025e
MEUR / EUR ComparisonActualizedInderesConsensusLow HighInderes
Revenue 173 197    841
EBITA (adj.) 12.8 14.6    60.5
EBIT 12.4 13.5    56.4
PTP 12.2 13.1    54.3
EPS (reported) 0.14 0.16    0.65
          
Revenue growth-% -18.6 % 13.7 %    7.8 %
EBITA-% (adj.) 7.4 % 7.4 %    7.2 %

Source: Inderes

Translation: Original published in Finnish on 10/20/2025 at 8:32 am EET.

Scanfil will publish its Q3 report on Friday at around 8:00 am EET. In our view, Scanfil has progressed in Q3 with the ramp-up of projects won last year, in addition to which the SRX acquisition has supported the figures inorganically in Q3. Thus, we expect Scanfil's operating profit to have finally turned to growth in Q3. However, we have marginally lowered our forecasts, as Scanfil did not close the ADCO acquisition in Q3 as originally scheduled (though we expect the acquisition to close in Q4). We estimate Scanfil will reiterate its guidance, although there may be slight downward pressure on the upper ends of the rather wide ranges, given the continued subdued macroeconomic picture in Europe.

Revenue should turn to organic growth

We estimate that the underlying tone of Scanfil's demand has been roughly similar to the satisfactory comparison period, as a clear pick-up in industrial activity has still been limited. However, we expect projects won last year to have supported the company's revenue, as deliveries should already accelerate after the H1 ramp-up phase. In addition, the SRX acquisition, completed last October, has supported inorganic growth by approximately 4–5 percentage points in Q3. Thus, we expect Scanfil's revenue to have grown by 14% in Q3 to 197 MEUR.

We expect revenue development to have turned slightly positive in Central and Northern Europe due to project wins, while reported growth in APAC is strong due to the acquisition. In the Americas, US trade policy may still have had positive short-term demand effects, although in the longer term and considering indirect effects, global trade restrictions are, in our opinion, also a bad thing for Scanfil.

We also expect the company to deliver earnings improvement driven by revenue growth

We estimate Scanfil's adjusted EBIT for Q3 to be 14.6 MEUR, 14% higher than in the comparison period. In our forecast, earnings growth is driven by organic revenue growth and the SRX acquisition. Of the regions, we expect the Americas, APAC, and Central Europe to have moderately improved their results, while in Northern Europe, the result to be flat year-on-year. We estimate profitability to have remained stable at Scanfil's baseline adjusted EBITA margin of just over 7% in Q3.

On the lower lines, our financial expense and tax forecasts are in line with Scanfil's normalized levels, although non-cash FX differences that are not material to the company as a whole could slightly impact financing costs and EPS. We expect Scanfil's EPS to have risen quite clearly from the comparison period, driven by the operating result. From a cash flow perspective, the report may be slightly weaker than the result, as the turnaround in revenue may have increased working capital, although the company still has room for improvement in working capital turnover.

Reiterating the guidance is the base scenario

Scanfil has issued guidance for the current year, according to which the company's 2025 revenue will be 780–920 MEUR and adjusted EBITA 55–68 MEUR. We expect the company to reiterate its guidance at this point in the year, as projects won last year and the SRX acquisition, which provided inorganic growth until Q3, as well as the ADCO and MB acquisitions, which are still expected to be completed in Q4, will act as buffers, even if the recovery in demand may still be limited. In our view, the upper ends of the guidance range are starting to look optimistic given the current situation, so a slight decrease in the upper ends or a moderate reduction in the mid-points of the ranges would not be a huge surprise.

Login required

This content is only available for logged in users

Create account

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Read more on company page

Key Estimate Figures17.07.2025

202425e26e
Revenue779.9844.01,005.7
growth-%-13.5 %8.2 %19.2 %
EBIT (adj.)54.960.975.7
EBIT-% (adj.)7.0 %7.2 %7.5 %
EPS (adj.)0.620.700.85
Dividend0.240.260.28
Dividend %2.9 %2.3 %2.5 %
P/E (adj.)13.316.413.5
EV/EBITDA7.610.48.2

Forum discussions

Scanfil itself also published a news release about this strengthening of the partnership at the end of last year (December 16, 2025). The most...
7/28/2026, 9:56 AM
by Derm
11
The Finnish industrial sector is currently showing signs of awakening. In this regard, a partnership opportunity with Valmet has emerged. Scanfil...
7/28/2026, 8:33 AM
by Dissidentti
8
Inderes Scanfil: Good execution on many fronts - Nordea - Inderes Net sales and adjusted EBITA were close to LSEG consensus in Q2. Scanfil kept...
7/17/2026, 6:33 AM
by Dissidentti
4
Antti has written a new company report on Scanfil following the Q2 results. Scanfil’s Q2 figures, released on Thursday, were operationally in...
7/17/2026, 5:27 AM
by Sijoittaja-alokas
4
Moving on to this, Tomra announced an interesting stock exchange release today. 1,200 reverse vending machines for the United Kingdom, starting...
7/16/2026, 6:42 PM
by Derm
6
April–June Revenue was EUR 259.0 million (202.2), an increase of 28.1% Organic revenue growth was 4.7% Comparable EBITA margin was 7.2% (7.0...
7/16/2026, 5:09 AM
by Jukka
9
Q2 earnings are just around the corner! The 19 investors who have submitted estimates so far are slightly more cautious than Antti and the broader...
7/13/2026, 1:06 PM
by Oscar Matheson
4